However, the transfer of CAR-T cells targeting overexpressed PC antigens such as mesothelin, CD133, and epidermal growth factor receptors (EGFRs) have proven ineffective in patients with PC [171]. This evidence concerns the gene PROM1 and pachyonychia congenita.